A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Amgen
Amgen
Amgen
Hoffmann-La Roche
Verastem, Inc.
Revolution Medicines, Inc.
Amgen
Deciphera Pharmaceuticals, LLC
Amgen
Vitrac Therapeutics, LLC
Allist Pharmaceuticals, Inc.
Navire Pharma Inc., a BridgeBio company
Criterium, Inc.
Erasca, Inc.